21 CFR, Parts 210 and 211

แชร์
ฝัง
  • เผยแพร่เมื่อ 12 มิ.ย. 2024
  • Troy Fugate is the VP and Co-founder of Compliance Insight (www.compliance-insight.com)
    Compliance Insight is a leading FDA regulatory and quality assurance consulting firm that offers a range of services to assist companies in navigating the complexities of FDA regulations. With their in-depth knowledge and expertise, Compliance Insight provides invaluable guidance and support to ensure compliance with FDA requirements.
    One of their key services is assisting companies with the 510(k) process. They understand the intricacies involved in preparing and submitting 510(k) applications for medical devices. Compliance Insight helps clients gather the necessary data, conduct thorough reviews, and ensure the application meets all regulatory standards, streamlining the path to FDA clearance.
    In addition, Compliance Insight has extensive experience in the emerging field of cell and gene therapies. They offer specialized guidance on navigating the unique regulatory landscape for these innovative therapies, helping clients understand and meet FDA requirements to bring their life-changing treatments to market.
    Another area of expertise for Compliance Insight is providing assistance with 483 and Warning Letter response and remediation. In the event of an FDA inspection resulting in observations or deficiencies (captured in Form 483), Compliance Insight supports companies in developing comprehensive and effective responses. Their team works closely with clients to address each observation, develop appropriate corrective actions, and ensure timely and compliant resolution.
    Whether it's navigating the 510(k) process, advancing cell and gene therapies, addressing 483 observations, or more; Compliance Insight's services encompass comprehensive regulatory support to help companies achieve and maintain FDA compliance, fostering successful product development and market approval.
    For more, visit us at www.compliance-insight.com

ความคิดเห็น • 11

  • @gustavopoueymirou-ortiz7981
    @gustavopoueymirou-ortiz7981 3 ปีที่แล้ว +1

    Excellent training. You got a 10 +

  • @benseghirloundja7274
    @benseghirloundja7274 4 ปีที่แล้ว

    Great training thanks a lot.

  • @joja2568
    @joja2568 ปีที่แล้ว

    Thank you. Very helpful!

  • @nareshtyagi2009
    @nareshtyagi2009 3 ปีที่แล้ว

    Very good thank u.

  • @pharmamanu7
    @pharmamanu7 3 ปีที่แล้ว +1

    Lecture is clear and very useful,, Thank you Sir

  • @curleyps6122
    @curleyps6122 3 ปีที่แล้ว +1

    thank you for the training
    though i have few questions
    may i know the exact difference between Batch and LOT
    what is in-process control
    would you suggest me how to obtain and remember all the 21cfr parts for GMP knowledge
    thank you

    • @thehealer8330
      @thehealer8330 2 ปีที่แล้ว

      What is the use ICH guidelines when 21 CFR already present? Sir plz give ur response. And how it corelate with each other?

  • @sakshigupta4177
    @sakshigupta4177 3 ปีที่แล้ว

    Very informative sir 🙏..... thanks

    • @JayhawkGuitar
      @JayhawkGuitar 2 ปีที่แล้ว

      Thanks for this overview. Very helpful.

  • @sakshigupta4177
    @sakshigupta4177 3 ปีที่แล้ว +1

    Have you made a video on EC Principles of GMP (Directive 91/356/EEC) Article 6 to Article 14
    If not then please share your knowledge on the above topic 🙏..... waiting for your next session

    • @sumagatla9446
      @sumagatla9446 2 ปีที่แล้ว

      I also want this topic sir